<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01560247</url>
  </required_header>
  <id_info>
    <org_study_id>EU-PRIISM-02</org_study_id>
    <nct_id>NCT01560247</nct_id>
  </id_info>
  <brief_title>Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry</brief_title>
  <acronym>PRIISM2</acronym>
  <official_title>Percutaneous Recanalization in Ischemic Stroke Management in Europe Observational Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MindFrame, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MindFrame, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the revascularization rate, clinical efficacy and safety of the CE-marked
      MindFrame System in ischemic stroke patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the revascularization rate, clinical efficacy and safety in a &quot;real-world
      setting&quot; of the CE-marked MindFrame System in ischemic stroke patients with thrombotic
      neurovascular occlusions caused by an embolus deemed appropriate for endovascular treatment.
      Target vessels include the basilar, internal carotid and middle cerebral (M1 and M2 segments)
      arteries.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural Efficacy</measure>
    <time_frame>Immediate postprocedure</time_frame>
    <description>The ability of the MindFrame System to restore blood flow by removing thrombus and establishing final Thrombolysis in Cerebral Infarction (TICI) 2b or 3 perfusion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>90 days postprocedure</time_frame>
    <description>The rate of device-related serious adverse events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Efficacy</measure>
    <time_frame>90 days postprocedure</time_frame>
    <description>The rate of modified Rankin Scale (mRS) score 0-2 at 90 days</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <description>Subjects in whom a MindFrame Device was employed for restoration of flow and clot removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mechanical thrombectomy</intervention_name>
    <description>Mechanical thrombectomy using a MindFrame device</description>
    <arm_group_label>Treatment Group</arm_group_label>
    <other_name>MindFrame</other_name>
    <other_name>Capture</other_name>
    <other_name>Flow</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The purpose of this registry is to compile data in a &quot;real world setting&quot;. All subjects in
        whom there is an attempt to use the device will be included in the registry. All subjects
        must be recruited according to the Mindframe System &quot;Instructions For Use&quot;.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of ischemic stroke for whom the physician has prescribed mechanical
             thrombectomy as appropriate therapy

        Exclusion Criteria:

          -  Intracranial hemorrhage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Soderman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2012</study_first_submitted>
  <study_first_submitted_qc>March 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2012</study_first_posted>
  <last_update_submitted>April 3, 2012</last_update_submitted>
  <last_update_submitted_qc>April 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Ischemic Stroke</keyword>
  <keyword>Revascularization</keyword>
  <keyword>Mechanical thrombectomy</keyword>
  <keyword>Neurothrombectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

